Susceptibility of HCT116 towards T cell mediated killing was slightly enhanced by IFN-γ pre-treatment (Figure 2A, right panel) which leads to an upregulation of MHC-I and HLA-A0201 on this tumor cell line [9]. The gene discussed is IFNG; the disease is neoplasm.